Clinical Trials

Phase 2 Active not recruiting

314 enrolled 12 charts

Papillomavirus Infections

NCT05555862 2025-05-18

anal HSIL HIV-

17 enrolled

Papillomavirus Infections

NCT06959563 2025-05-13

9vHPV-BCG

Phase EARLY_PHASE1 Active not recruiting

20 enrolled

Papillomavirus Infections

NCT04708041 2025-04-20

V503-069

700 enrolled

Papillomavirus Infections

NCT04199689 2025-03-25

V503-049

Phase 1/2 Not yet recruiting

6,033 enrolled

Papillomavirus Infections

NCT00733122 2025-03-03

Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)

Phase 3 Withdrawn

Papillomavirus Infections

NCT05829629 2025-02-14

Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women

Phase 1 Recruiting

20 enrolled

Papillomavirus Infections

NCT03610581 2025-02-04

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Phase 1/2 Terminated

9 enrolled 13 charts

Papillomavirus Infections

NCT06797986 2025-01-29

A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects with HPV Positive HNSCC.

37 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

NCT06281119 2025-01-07

Clinical Study to Evaluate SIIPL QHPV Vaccine (CERVAVAC®) in Women Living with HIV Aged 15-25 Years

Phase 3 Not yet recruiting

450 enrolled

Papillomavirus Infections

NCT06454175 2025-01-06

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

Phase 1 Active not recruiting

72 enrolled

Condylomata Acuminata, Papillomavirus Infections

NCT05285826 2024-12-16

Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)

8,100 enrolled

Papillomavirus Infections

NCT03487549 2024-11-27

COVE-1

56 enrolled 29 charts

DNA Virus Infections, Skin Diseases, Skin Diseases, Infectious, Tumor Virus Infections, Virus Diseases, Warts, Skin Diseases, Viral, Papillomavirus Infections

NCT03981822 2024-11-27

CARE-1

Phase 1/2 Not yet recruiting

105 enrolled 24 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Skin Diseases, Skin Diseases, Infectious, Virus Diseases, Warts, Sexually Transmitted Diseases, Viral, Skin Diseases, Viral, Papillomavirus Infections

NCT06672653 2024-11-04

PREPAP

66 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04199078 2024-10-31

PALOMA2

Phase NA Completed

288 enrolled

Papillomavirus Infections

NCT04472377 2024-10-03

HPV Typing Between Self- and Physician-sampled

Phase NA Completed

1,210 enrolled 7 charts

Vaginal Discharge, Papillomavirus Infections

NCT06439433 2024-06-03

ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection

119 enrolled

Papillomavirus Infections

NCT04895020 2024-04-17

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Phase 3 Recruiting

1,200 enrolled

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT05027776 2024-04-17

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Phase 3 Recruiting

1,348 enrolled

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Papillomavirus Infections

NCT05916911 2024-02-07

Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)

Phase 4 Unknown

120 enrolled

Squamous Intraepithelial Lesions, Papillomavirus Infections

NCT06207175 2024-01-23

A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine

Phase 3 Unknown

1,260 enrolled

Papillomavirus Infections

NCT03912831 2023-12-26

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

Phase 1 Terminated

8 enrolled 13 charts

Neoplasms, Papillomavirus Infections

NCT05372016 2023-11-24

Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

1,200 enrolled

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT06111911 2023-11-01

Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma)

Phase NA Completed

900 enrolled

Papillomavirus Infections

NCT06041061 2023-09-18

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years

18,000 enrolled

Papillomavirus Infections

NCT04490512 2023-06-26

Study of FluBHPVE6E7 in HPV-16 Infected Women

Phase 1 Completed

28 enrolled

Papillomavirus Infections

NCT00380367 2023-05-31

Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)

110 enrolled 7 charts

Papillomavirus Infections

NCT03900572 2023-04-13

A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine

Phase 1 Completed

90 enrolled

Uterine Cervical Neoplasms, Condylomata Acuminata, Papillomavirus Infections

NCT04965350 2023-04-13

Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females

1,100 enrolled

Papillomavirus Infections

NCT05694728 2023-01-23

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine